Abstract
The size distribution of saline and bronchodilator (terbutaline) aerosol droplets generated from four widely used jet nebulisers (Acorn, Upmist, Turret, and Inspiron Mini-neb) has been measured with a Malvern 2200 Laser Particle Sizer. The mass median diameter of aerosol droplets generated by each nebuliser was strongly influenced by the driving flow rate of compressed air. By increasing the flow rate from 4 to 8 1 min-1 mass median diameters were halved (p less than 0.01) and there was an increase in the mass of aerosol within the optimum respirable range (less than 5 micron). To achieve this range the following individual flow rates were required: Turret 4 1 min-1, Acorn and Upmist 6 1 min-1, and Inspiron Mini-neb 8 1 min-1. A significant inverse relation (p less than 0.001) was found between mass median diameter and the geometric standard deviation, indicating that the aerosols were smaller but more heterodisperse at high flow rates. Changes in drug concentration had little effect on aerosol size. In 72% of the nebulisations followed to dryness there was no significant change in mass median diameter during the course of nebulisation and in the remainder it was less than 1.3 micron.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Hodson M. E., Penketh A. R., Batten J. C. Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis. Lancet. 1981 Nov 21;2(8256):1137–1139. doi: 10.1016/s0140-6736(81)90588-2. [DOI] [PubMed] [Google Scholar]
- Lourenço R. V., Cotromanes E. Clinical aerosols. I. Characterization of aerosols and their diagnostic uses. Arch Intern Med. 1982 Nov;142(12):2163–2172. [PubMed] [Google Scholar]
- Mercer T. T., Tillery M. I., Chow H. Y. Operating characteristics of some compressed-air nebulizers. Am Ind Hyg Assoc J. 1968 Jan-Feb;29(1):66–78. doi: 10.1080/00028896809342983. [DOI] [PubMed] [Google Scholar]
- Miller W. F. Aerosol therapy in acute and chronic respiratory disease. Arch Intern Med. 1973 Jan;131(1):148–155. [PubMed] [Google Scholar]
- Paterson J. W., Woolcock A. J., Shenfield G. M. Bronchodilator drugs. Am Rev Respir Dis. 1979 Nov;120(5):1149–1188. doi: 10.1164/arrd.1979.120.5.1149. [DOI] [PubMed] [Google Scholar]
- Swift D. L. Aerosols and humidity therapy. Generation and respiratory deposition of therapeutic aerosols. Am Rev Respir Dis. 1980 Nov;122(5 Pt 2):71–77. doi: 10.1164/arrd.1980.122.5.71. [DOI] [PubMed] [Google Scholar]
- Woolcock A. J. Inhaled drugs in the prevention of asthma. Am Rev Respir Dis. 1977 Feb;115(2):191–194. doi: 10.1164/arrd.1977.115.2.191. [DOI] [PubMed] [Google Scholar]
- Woolcock A. J. Inhaled drugs in the prevention of asthma. Am Rev Respir Dis. 1977 Feb;115(2):191–194. doi: 10.1164/arrd.1977.115.2.191. [DOI] [PubMed] [Google Scholar]